Drugs / F19
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004042 | Nov 1998 → Jul 2001 | colorectal cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F19 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004042 ↗ |
| Known as | BIBH-1 | “monoclonal antibody F19 (BIBH-1) administered weekly by intravenous infusion” NCT00004042 ↗ |
| Modality | Monoclonal antibody | “monoclonal antibody F19 (BIBH-1)” NCT00004042 ↗ |
| Route | Intravenous | “administered weekly by intravenous infusion” NCT00004042 ↗ |